HC
VCNX

HNP Capital’s Vaccinex, Inc. Common Stock VCNX Stock Holding History

HNP Capital’s Portfolio VCNX Stock Details VCNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		$4K Hold
48
– – ﹤0.01% 128
2022
Q4 		$6.45K Hold
48
– – ﹤0.01% 131
2022
Q3 		$5K Hold
48
– – ﹤0.01% 134
2022
Q2 		$11K Hold
48
– – ﹤0.01% 143
2022
Q1 		$13K Buy
+48
New +$13.3K ﹤0.01% 152

Other funds holding VCNX

ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

HNP Capital's VCNX Position: Q1 2023 in Review

HNP Capital held its Vaccinex, Inc. Common Stock (VCNX) position steady in Q1 2023 at 48 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #128.

HNP Capital first reported a position in VCNX in Q1 2022 and has held it in 5 quarters since. The position peaked at $13K in Q1 2022. 24 funds tracked by Wall St. Rank hold VCNX as of Q1 2023.

  • HNP Capital held 48 shares of Vaccinex, Inc. Common Stock worth $4K as of Q1 2023.
  • HNP Capital left its Vaccinex, Inc. Common Stock share count unchanged in Q1 2023.
  • Vaccinex, Inc. Common Stock made up ﹤0.01% of HNP Capital's portfolio in Q1 2023, its #128 holding.
  • HNP Capital first reported a position in Vaccinex, Inc. Common Stock in Q1 2022 and has held it in 5 quarters since.
  • HNP Capital's Vaccinex, Inc. Common Stock position peaked at $13K in Q1 2022.
  • 24 funds tracked by Wall St. Rank held Vaccinex, Inc. Common Stock as of Q1 2023.

Based on HNP Capital's 13F filing for Q1 2023, filed 18 May 2023.